Melbourne founder James Sackl is building two companies with a long horizon while sharing practical insights on innovation, capital, and execution.
Every founder has a moment that changes the trajectory of their career. For James Sackl, one defining moment came during the COVID 19 pandemic when he designed an all in one rapid antigen test pen that ultimately generated 130 million dollars in sales. The achievement did not come from inventing new biotechnology. Instead, it came from rethinking how existing technologies could be combined into a product that ordinary people could use with ease. That experience continues to shape how Sackl approaches innovation today as he builds Wallace Biotechnologies and Terraform Technologies while publishing practical essays through his Golden Age project.
Building Companies for the Long Term
Based in Melbourne, Sackl is the founder of two companies designed for multi decade operation. Wallace Biotechnologies focuses on improving human health span, which the company defines as the years people remain healthy, capable, and productive.
Its long term mission is ambitious. Wallace Biotechnologies has publicly stated an objective of supporting a healthier population of 100 billion people within 100 years. Rather than focusing on short term growth, the company has been structured with longevity and resilience in mind.
Terraform Technologies approaches another fundamental challenge. The company is focused on energy and resources, built on the premise that abundant solar energy has the potential to reduce the cost of essential resources at scale. Its name reflects the Kardashev framework, which measures civilizations by the amount of energy they are capable of harnessing. For Sackl, this represents a practical engineering challenge rather than an abstract concept, with an emphasis on building infrastructure that can endure for generations.
As Sackl explains, “Wallace and Terraform are both built for multi decade horizons. Most Australian companies are not. We are operationally independent and structured to survive external shocks rather than just chase growth. That is a deliberate response to what I learned operating across companies over twenty years.”
Innovation Through Better Design
The rapid antigen test pen remains one of the clearest examples of Sackl’s philosophy toward innovation. Rather than relying on a scientific breakthrough, the product combined existing components into a more practical and accessible design for consumers.
“Business model innovation beats technology innovation in mature categories almost every time. The components of the COVID test pen were all old. What was new was putting them together in one object that a non clinical person could use without instructions. That is product design, not biotech.”
That perspective has become a guiding principle across his work. Instead of pursuing novelty for its own sake, Sackl emphasizes creating products and business models that solve practical problems with greater simplicity and efficiency.
Lessons From a Founder Who Started Small
Long before building companies with global ambitions, Sackl began his entrepreneurial journey by walking the streets of Melbourne selling advertising space for a website that had not yet been built. He secured 21,000 dollars in pre orders before creating the platform, proving demand before investing significant resources into development.
The lesson continues to influence his work today.
“Sell first, build second. That is the principle I learned at twenty one walking the streets of Melbourne with a website that did not yet exist. Twenty years later, it is still the most reliable principle I know for risking a new venture.”
Over the following two decades, Sackl built experience across software, training, agriculture, migration, and consumer products before applying those lessons to his current long horizon ventures.
Writing the Work, Not the Marketing
Alongside his operating responsibilities, Sackl publishes long form essays through Golden Age. The essays explore decision making, capital allocation, leverage, attention, and founder execution in the age of artificial intelligence. Rather than motivational writing, the collection is intended for founders and operators seeking practical frameworks informed by direct experience.
“The present moment is the most resourceful era any human has ever lived through. Most people are not using it well. The essays at jamessackl.com.au are written for the operator who already has the resources of the age in front of them and is trying to work out what to do with them.”
By writing under his own name, Sackl provides readers with direct access to his thinking rather than relying on traditional corporate communications.
Looking Toward the Next Century
James Sackl’s story is not defined by a single successful product or company. Instead, it reflects a consistent approach to building businesses that combine practical execution with long term ambition. From validating ideas before building them to designing organizations intended to endure across decades, his work demonstrates that sustainable innovation often comes from disciplined thinking as much as technical advancement.
Readers interested in long horizon company building, practical founder insights, and the future of health, energy, and innovation can explore more at www.jamessackl.com.au. Additional information about Wallace Biotechnologies is available at www.wallacebio.com, while Terraform Technologies can be explored at www.terraformworlds.com. James Sackl also shares insights through LinkedIn, X, Crunchbase, and Wikidata. Business enquiries can be directed to [email protected].
